Literature DB >> 22564372

Spontaneous expression of FRA16B in a non-consanguineous couple experiencing multiple fetal losses.

Sivasankaran Aswini1, Thankanadar Jegatheesan, Nallathambi Chandra.   

Abstract

The association between fragile sites and human genetic diseases is still debatable. Although FRAXA and FRAXE have been found to be associated with mental retardation and FRA11B possibly with Jacobsen syndrome, no other autosomal fragile site has yet been found to have a direct correlation with a genetic disorder; however, the frequency of fragile sites in infertile couples has been reported to be higher than in a control group. The occurrence of a fragile site can therefore be a possible risk factor causing considerable anxiety to the clinician and probably requires follow up with appropriate genetic counseling. The present study reports heterozygosity for FRA16B in both partners of an infertile non-consanguineous couple married for 9 years. They had been referred for cytogenetic evaluation with the complaint of multiple fetal losses.
© 2012 The Authors. Journal of Obstetrics and Gynaecology Research © 2012 Japan Society of Obstetrics and Gynecology.

Entities:  

Mesh:

Year:  2012        PMID: 22564372     DOI: 10.1111/j.1447-0756.2012.01850.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

1.  Enhanced Expression of FRA16B using AT-Rich DNA Binding Chemicals in a Woman with Secondary Amenorrhoea.

Authors:  Gunasekaran Bhavani; S Sivaprakash; Chandra R Samuel; Sathiyavedu Thyagarajan Santhiya
Journal:  J Clin Diagn Res       Date:  2017-06-01

2.  De novo c.2455C>T mutation of NPR2 gene in a fetus with shortened long bones and a ventricular septal defect conceived by a mother with a fragile site at 16q22.1 and a father with a rare heterochromatic variant of chromosome 4 from Vietnam.

Authors:  Thi Minh Thi Ha; Tran Thao Nguyen Nguyen; Thi Mai Ngan Nguyen; Huu Nguyen Nguyen
Journal:  Mol Genet Genomic Med       Date:  2021-03-13       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.